News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,711 Results
Type
Article (8036)
Company Profile (140)
Press Release (476534)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166763)
Career Advice (305)
Deals (25740)
Drug Delivery (7)
Drug Development (52878)
Employer Resources (14)
FDA (9762)
Job Trends (8579)
News (238254)
Policy (17922)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (487)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33161)
ALS (104)
Alzheimer's disease (975)
Antibody-drug conjugate (ADC) (262)
Approvals (10376)
Artificial intelligence (319)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6967)
BIO (36)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (28)
Breast cancer (508)
Cancer (3639)
Cardiovascular disease (217)
Career advice (246)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (47866)
Collaboration (1242)
Commercialization (3)
Compensation (1465)
Complete response letters (34)
COVID-19 (756)
CRISPR (63)
C-suite (746)
Cystic fibrosis (85)
Data (5643)
Denatured (4)
Depression (102)
Dermatology (60)
Diabetes (343)
Diagnostics (4183)
Digital health (38)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (163)
Earnings (73705)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87610)
Executive appointments (702)
FDA (12384)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (916)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (289)
Government (951)
Grass and pollen (2)
Guidances (281)
Healthcare (9330)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (944)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (253)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (7)
Liver cancer (44)
Longevity (16)
Lung cancer (508)
Lymphoma (250)
Machine learning (27)
Management (3)
Manufacturing (532)
Marketing (8)
MASH (118)
Medical device (8657)
Medtech (8799)
Mergers & acquisitions (14383)
Metabolic disorders (706)
mRNA (54)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1821)
NextGen: Class of 2026 (3153)
Non-profit (846)
Obesity (223)
Opinion (10)
Ovarian cancer (158)
Pain (171)
Pancreatic cancer (196)
Parkinson's disease (201)
Partnered (12)
Patents (473)
Patient recruitment (506)
Peanut (31)
People (41249)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15466)
Phase 2 (21373)
Phase 3 (14399)
Pipeline (7298)
Policy (18)
Postmarket research (1572)
Preclinical (6539)
Press Release (34)
Prostate cancer (189)
Psychedelics (7)
Radiopharmaceuticals (190)
Rare diseases (570)
Real estate (3021)
Recruiting (6)
Regulatory (14820)
Reports (21)
Research institute (582)
Resumes & cover letters (46)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (320)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (37)
Last 7 days (294)
Last 30 days (1676)
Last 365 days (19036)
2026 (12232)
2025 (19251)
2024 (22987)
2023 (26539)
2022 (34594)
2021 (37168)
2020 (33468)
2019 (23258)
2018 (17473)
2017 (18768)
2016 (17923)
2015 (24264)
2014 (21679)
2013 (18138)
2012 (20221)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (302)
Arkansas (11)
Asia (17881)
Australia (2099)
California (11949)
Canada (3136)
China (519)
Colorado (482)
Connecticut (409)
Delaware (208)
Europe (24623)
Florida (1788)
Georgia (379)
Hawaii (3)
Idaho (46)
Illinois (699)
India (50)
Indiana (314)
Iowa (15)
Japan (398)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1201)
Massachusetts (7845)
Michigan (307)
Minnesota (559)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (115)
New Hampshire (60)
New Jersey (2618)
New Mexico (12)
New York (2820)
North Carolina (1275)
North Dakota (4)
Northern California (5986)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2248)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4961)
Tennessee (119)
Texas (1934)
United States (38812)
Utah (360)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (926)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,711 Results for "cerapedics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cerapedics Announces Supplier Agreement with Vizient for PearlMatrix® P-15 Peptide Enhanced Bone Graft
April 26, 2026
·
6 min read
Press Releases
Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft
December 18, 2025
·
7 min read
Press Releases
Cerapedics’ PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use
January 14, 2026
·
6 min read
Press Releases
Cerapedics Announces First U.S. Patient Treated with PearlMatrix™ P-15 Peptide Enhanced Bone Graft following FDA approval
July 8, 2025
·
6 min read
Cerapedics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Cerapedics Inc. today announced that Valeska Schroeder , Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference.
January 5, 2024
·
1 min read
Press Releases
Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion
June 23, 2025
·
8 min read
Policy
Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion
Cerapedics Inc., a commercial-stage orthopedics company dedicated to redefining the standard of care for bone repair, announced that it has filed the final module in the Pre-Market Approval application with the U.S. Food and Drug Administration for its investigational P-15 Peptide Enhanced Bone Graft.
January 4, 2024
·
3 min read
Business
Cerapedics™ Announces Expansion of Headquarters to Support Growth of its Bone Graft Products
Cerapedics Inc. announced it is expanding its headquarters in the Denver metro area to support the growth of its products, which include the U.S. Food and Drug Administration -approved i-FACTOR® bone graft for cervical spinal fusion and its next-generation product currently being evaluated for lumbar spinal fusion.
July 19, 2023
·
2 min read
BioMidwest
Cerapedics Reinforces Commitment to Level 1 Evidence with Long-Term Results from Six-Year Pivotal IDE Cervical Study Demonstrating 98.6% Spine Fusion Rates in Patients Treated With i-FACTOR®
Cerapedics Inc., a commercial-stage orthopedics company dedicated to redefining the standard of care for bone repair, announced long-term follow-up data from its pivotal IDE study of i-FACTOR Peptide-Enhanced Bone Graft.
October 17, 2023
·
4 min read
Business
Cerapedics Appoints Valeska Schroeder Chairman and Chief Executive Officer
Cerapedics Inc., a commercial-stage ortho-biologics company dedicated to enhancing the science of bone repair, announced today that Valeska Schroeder has been appointed Chief Executive Officer effective November 1st, while continuing as Chairman of the Company’s Board of Directors.
October 10, 2022
·
2 min read
1 of 48,472
Next
